We aim to identify differentially expressed genes between enasidenib and DMSO treated CD71+ erythroid progenitors. We first enriched CD34+ cells from UCB and cultured them for 6 days in StemSpan II wi
ATAC-seq was performed in HUDEP-2 cells grown in expansion phase medium following the OMNI-ATAC protocol (Corces MR, et al. Nat. Methods, 2017). Overall design: 3 ATAC-seq replicates were performed in
